Inventor · disambiguated record
Jason Tierney
Also filed as: TIERNEY JASON · TIERNEY JASON PAUL
11 granted patents·5 pending applications·13 citations·filing 2003–2023
83Inventor score
Files withANIMA BIOTECH INC6BLACKTHORN THERAPEUTICS INC2CALCHAN LTD2NEUMORA THERAPEUTICS INC2ASTRAZENECA AB1
Top patents by PatentIndex Score
16 records- 0189US11248001B2PCSK9 inhibitors and methods of use thereofASTRAZENECA AB·Filed 2020·Granted Feb 15, 2022·6 cites·6 claims
- 0277US11186577B2Vasopressin receptor antagonists and products and methods related theretoBLACKTHORN THERAPEUTICS INC·Filed 2018·Granted Nov 30, 2021·2 cites·11 claims
- 0375US10538530B2Vasopressin receptor antagonists and products and methods related theretoBLACKTHORN THERAPEUTICS INC·Filed 2018·Granted Jan 21, 2020·1 cites·104 claims
- 0467US11858943B2Vasopressin receptor antagonists and products and methods related theretoNEUMORA THERAPEUTICS INC·Filed 2021·Granted Jan 2, 2024·0 cites·16 claims
- 0561US9585886B2ASK1 inhibiting pyrrolopyrimidine derivativesCALCHAN LTD·Filed 2015·Granted Mar 7, 2017·1 cites·16 claims
- 0661US9045485B2ASK 1 inhibiting pyrrolopyrimidine derivativesWITTY DAVID R·Filed 2011·Granted Jun 2, 2015·1 cites·17 claims
- 0759US12152038B2Vasopressin receptor antagonists and products and methods related theretoNEUMORA THERAPEUTICS INC·Filed 2021·Granted Nov 26, 2024·0 cites·123 claims
- 0859US7304064B21-[(indol-3-yl)carbonyl]piperazine derivativesORGANON NV·Filed 2003·Granted Dec 4, 2007·2 cites·8 claims
- 0954US12428413B2Rho kinase inhibitors and compositions and methods of use thereofCHDI FOUNDATION INC·Filed 2020·Granted Sep 30, 2025·0 cites·19 claims
- 1052US12404283B2c-MYC mRNA translation modulators and uses thereof in the treatment of cancerANIMA BIOTECH INC·Filed 2023·Granted Sep 2, 2025·0 cites·38 claims
- 1150US12344600B2c-Myc mRNA translation modulators and uses thereof in the treatment of cancerANIMA BIOTECH INC·Filed 2023·Granted Jul 1, 2025·0 cites·17 claims
- 1248US2022370431A1C-myc mrna translation modulators and uses thereof in the treatment of cancerANIMA BIOTECH INC·Filed 2022·Application pending·0 cites
- 1346US2023212131A1Collagen 1 translation inhibitors and methods of use thereofANIMA BIOTECH INC·Filed 2021·Application pending·0 cites
- 1446US2023150980A1Collagen 1 translation inhibitors and methods of use thereofANIMA BIOTECH INC·Filed 2021·Application pending·0 cites
- 1545US2023116201A1Collagen 1 translation inhibitors and methods of use thereofANIMA BIOTECH INC·Filed 2021·Application pending·0 cites
- 1642US2017210748A1Ask 1 inhibiting pyrrolopyrimidine derivativesCALCHAN LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jason Tierney files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →